Advances in Environmental Sciences

Advances in Environmental Sciences

You are here › Home

Advances in Environmental Sciences - International Journal of the Bioflux Society

Online ISSN: 2066-7647
Print ISSN: 2066-7620
ISSN-L: 2066-7620

Published annually by Bioflux Publishing House.

Contact for submission:
Petrescu-Mag I. V. – ioan.mag@usamvcluj.ro

 

The journal covers all fields of environmental sciences, connected to life sciences, geology, physics, chemistry, economics, policies, or legislation (both theoretical and applied issues).

AES Bioflux offers an excellent opportunity to publish original research articles, reviews, or short communications, both in print and online, in color, open access. Our policy allows the author(s) to retain copyright without restrictions. This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided that the original author and source are properly credited.

AES Bioflux is an international peer-reviewed journal. Each published article is independently evaluated by two Scientific Reviewers and at least one linguist. The peer-review policy of AES Bioflux is double-blind peer review. The editors use software to screen for plagiarism. Acceptance rate: approximately 50%. Electronic submission is required.

Because many authors withdrew their manuscripts in final form just before the payment of the publication fee, our policy was changed on 20 February 2019. The publication fee was replaced by a processing fee (250 USD), which is paid after a preliminary evaluation (not at the end of the process).

Our evaluation process has two steps:

  1. Preliminary evaluation by the editor (the author receives a preliminary acceptance or rejection);
  2. External double-blind peer review (at this stage, the author receives the final decision: acceptance or rejection).

Please note that if the manuscript is not published, the author or his/her institution receives a refund (except in cases of poor author responsiveness, withdrawal, or rejection due to multiple submissions).

Authors are informed about the final decision (acceptance or rejection) within 3–8 weeks after submission. The average overall time from manuscript submission to publication is 10 weeks. Faster processing involves a priority fee (50 USD).

 

Manuscript processing fee: 250 USD (or equivalent in EURO or RON)
Manuscript processing fee with priority: 300 USD (or equivalent in EURO or RON)
Publication fee: 0 USD

The journal has a waiver policy for authors from developing countries (only in cases of very high-quality manuscripts). When the first author of the manuscript is a member of the AES Bioflux Expanded Editorial Board, no processing fee is required.

Please attach a scanned payment document and send it by email to: ioan.mag@usamvcluj.ro

 

Payment details:
Bioflux SRL

SWIFT code: BTRLRO22

Account no.: 213USDCRT00L2861401

IBAN:

USD: RO68BTRL01302202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
EURO: RO19BTRL01304202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
RON: RO44BTRL01301202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)

 

Statement of human and animal rights

When reporting experiments involving human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible institutional and national committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000.

If there is doubt as to whether the research was conducted in accordance with the Helsinki Declaration, authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the relevant aspects of the study.

When reporting experiments involving animals, authors should indicate whether institutional and national guidelines for the care and use of laboratory animals were followed (International Committee of Medical Journal Editors – Uniform Requirements for Manuscripts Submitted to Biomedical Journals, February 2006 – cited by PubMed/Medline).

 

Statement of informed consent

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless essential for scientific purposes and written informed consent has been obtained.

Informed consent requires that identifiable patients be shown the manuscript prior to publication. Authors should identify individuals who provided writing assistance and disclose the funding source for such assistance.

Identifying details should be omitted whenever possible. Complete anonymity is difficult to achieve, and informed consent should be obtained whenever there is doubt. Masking the eye region in photographs is not sufficient to guarantee anonymity.

If identifying characteristics are altered to protect anonymity, authors must ensure that scientific meaning is not distorted and editors should be informed accordingly (International Committee of Medical Journal Editors – Uniform Requirements for Manuscripts Submitted to Biomedical Journals, February 2006 – cited by PubMed/Medline).

 

Conflict-of-interest statement

Public trust in the peer-review process and the credibility of published articles depend on the proper handling of conflicts of interest during writing, peer review, and editorial decision-making.

A conflict of interest exists when an author, reviewer, editor, or their institution has financial or personal relationships that could inappropriately influence their actions. These relationships may range from negligible to significant potential influence.

Financial relationships (employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts and may undermine credibility.

Conflicts may also arise from personal relationships, academic competition, or intellectual bias. The Chief Editor takes appropriate measures to prevent such conflicts through established peer-review policies.

 

Authors’ responsibilities

  • All authors must have made significant contributions to the research
  • Authors must provide corrections or retractions if errors are identified
  • Authors must provide a complete list of references
  • Information on financial support must be included in the Acknowledgements section
  • Submission of the same research to more than one journal is prohibited

 

Peer-review, publication policies, and publication ethics

  • Reviews are conducted objectively and independently
  • Reviewers must have no conflicts of interest
  • Manuscripts are treated confidentially prior to publication
  • Bioflux Publishing takes reasonable measures to detect and prevent research misconduct
  • Allegations of misconduct are handled appropriately by the publisher and editors
  • Corrections, clarifications, retractions, and apologies are accepted
  • Corrections cannot be made directly in the original published article; they must appear as a separate Note or Erratum
  • Retractions are issued by the publisher in cases of plagiarism or serious ethical concerns

This is an open-access journal distributed under the Creative Commons Attribution License (CC-BY), permitting unrestricted use, distribution, and reproduction, provided the original author and source are credited.

If the journal ceases publication, Bioflux Publishing has agreements with several databases authorized to preserve and republish archived content in unlimited electronic and printed copies.

Bioflux Publishing is archived by the Legal Deposit of Bucharest (National Library of Romania) and by the County Legal Deposit in Cluj-Napoca (Octavian Goga Library).  


Data Sharing Policy

1. Policy Statement

AES Bioflux is committed to promoting transparency, reproducibility, and integrity in scientific research. We support responsible data sharing as an essential component of scholarly communication and encourage authors to make the data underlying their findings openly available whenever possible.

This policy applies to all manuscripts submitted to the journal and is consistent with international standards for editorial best practices and research transparency.

2. Author Responsibilities

Authors are required to:

  • Include a Data Availability Statement in all submitted manuscripts.
  • Clearly indicate whether the data supporting the findings of the study are:
    • Publicly available,
    • Available upon reasonable request, or
    • Restricted due to ethical, legal, or confidentiality considerations.
  • Ensure that shared data are accurate, complete, and sufficiently documented to allow replication and verification of the reported results.

Authors are strongly encouraged to deposit their data in recognized public repositories appropriate to their discipline.

3. Data Availability Statement

All manuscripts must include a Data Availability Statement specifying one of the following:

  • The repository name, persistent identifier (e.g., DOI), and access link if data are publicly available.
  • The conditions under which data may be accessed if restrictions apply.
  • A clear explanation if no new data were generated or analyzed.

Example statement:

"The data supporting the findings of this study are available in [repository name] at [DOI or URL], or from the corresponding author upon reasonable request."

4. Recommended Data Repositories

Authors are encouraged to use trusted repositories that provide:

  • Persistent identifiers (e.g., DOI)
  • Long-term preservation
  • Public accessibility
  • Appropriate metadata and documentation

Examples include institutional repositories, discipline-specific repositories, or general repositories such as Zenodo, Dryad, Figshare, or equivalent platforms.

5. Ethical and Legal Considerations

Data sharing must comply with:

  • Patient privacy and confidentiality requirements
  • Informed consent provisions
  • Institutional and national regulations
  • Ethical approval conditions

Sensitive data involving human participants must be de-identified prior to sharing, unless explicit consent for identifiable data sharing has been obtained.

Where legal or ethical restrictions prevent public sharing, authors must clearly state these limitations.

6. Editorial and Peer Review Access

Editors and peer reviewers may request access to underlying data during the review process to evaluate the scientific validity of the manuscript. Authors must provide such data upon request, unless prohibited by legal or ethical constraints.

Failure to provide requested data may result in rejection of the manuscript.

7. Compliance and Enforcement

Failure to comply with this policy may result in:

  • Manuscript rejection,
  • Publication delays,
  • Retraction of published articles if data integrity concerns arise.

The journal reserves the right to request data verification at any stage before or after publication.

8. Exceptions

Exceptions to data sharing requirements may be granted in cases involving:

  • Legal restrictions,
  • Ethical or privacy concerns,
  • Proprietary or confidential data.

Such exceptions must be clearly justified in the Data Availability Statement.

9. Policy Scope and Alignment

This policy is aligned with international editorial standards and supports the principles of:

  • Research transparency
  • Reproducibility
  • Scientific integrity
  • Responsible data stewardship

The journal periodically reviews and updates this policy to maintain compliance with evolving indexing and ethical standards.

10. Contact Information

Questions regarding this policy should be directed to the Editorial Office at:

ioan.mag@usamvcluj.ro


Advertising policy

Our journals do not accept or display any form of advertising, sponsored content, or commercial promotions. No third-party advertising networks are used, and there is no advertising revenue associated with our publications.

08.03.2009. 03:26

AES Bioflux

Page format

Instructions to authors

Submission letter

Reviewer information pack

Volume 18(1)/2026 (December, 30)

Volume 17(1)/2025 (December, 30)

Volume 16(1)/2024 (December, 30)

Volume 15(2)/2023 (December, 30)

Volume 15(1)/2023 (June, 30)

Volume 14(2)/2022 (December, 30)

Volume 14(1)/2022 (June, 30)

Volume 13(3)/2021 (December, 30)

Volume 13(2)/2021 (August, 30)

Volume 13(1)/2021 (April, 30)

Volume 12(3)/2020 (December, 30)

Volume 12(2)/2020 (August, 30)

Volume 12(1)/2020 (April, 30)

Volume 11(3)/2019 (December, 30)

Volume 11(2)/2019 (August, 30)

Volume 11(1)/2019 (April, 30)

Volume 10(3)/2018 (December, 30)

Volume 10(2)/2018 (August, 30)

Volume 10(1)/2018 (April, 30)

Volume 9(3)/2017 (December, 30)

Volume 9(2)/2017 (August, 30)

Volume 9(1)/2017 (April, 30)

Volume 8(3)/2016 (December, 30)

Volume 8(2)/2016 (August, 30)

Volume 8(1)/2016 (April, 30)

Volume 7(3)/2015 (December, 30)

Volume 7(2)/2015 (June, 30)

Volume 7(1)/2015 (April, 30)

Volume 6(3)/2014 (December, 30)

Volume 6(2)/2014 (June, 15)

Volume 6(1)/2014 (April, 15)

Special Issue 2014 (March, 27)

Volume 5(3)/2013 (October, 15)

Volume 5(2)/2013 (June, 15)

Volume 5(1)/2013 (April, 15)

Volume 4(3)/2012 (December, 30)

Volume 4(2)/2012 (August, 30)

Volume 4(1)/2012 (June, 30)

Volume 3(3)/2011 (December, 30)

Volume 3(2)/2011 (August, 30)

Volume 3(1)/2011 (June, 30)

Volume 2(2)/2010 (November, 30)

Volume 2(1)/2010 (July, 31)

Volume 1(2)/2009 (December, 30)

Volume 1(1)/2009 (August, 30) 

Volume Pilot (b)/2008 (December, 30) - available printed only

Volume Pilot (a)/2007 (December, 30) - available printed only